ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension
The goal of this clinical trial is to evaluate the dose response effect on cardiovascular disease risk factors of a Black Garlic Extract in subjects with Grade I Hypertension. The main questions it aims to answer are:

If the reduction in blood pressure (systolic and diastolic) is in a dose-response manner
If the changes in lipid profile are in a dose-response manner

Participants will be randomly assign to a low dose (250 mg/day), high dose (600 mg/day) or placebo of a standardized Garlic Extract (ABG+/GarlACE) during 12 weeks
- EligibilityCriteria: Inclusion Criteria:  Men and women with Grade I Hypertension (systolic blood pressure between 130 and 139 mmHg; and diastolic blood pressure between 80 to 89 mmHg) without taking any antihypertensive drug  Exclusion Criteria:  Acute or chronic kidney disease including dyslipidemia due to nephrotic syndrome.- - Hypothyroidism Having previously suffered a myocardial infarction or stroke Pharmacological treatment with insulin, sulfonylureas, protease inhibitors Chronic gastrointestinal disease Pregnancy or intention to become pregnant during the study period. Breastfeeding Allergy or intolerance to garlic High alcohol consumption (>14 units per week) Smokers - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 18 Years - MaximumAge: 75 Years - StdAgeList: Adult, Older Adult